Harriet

Harriet is 35 and works part time as a project manager. She is married with one child, who is two.

When Harriet’s mum and aunt were diagnosed with MND, she had pre-symptomatic genetic testing to inform decisions over having another child. She was told she carries the C9orf72 gene variant and is currently undergoing pre-implantation genetic testing.

Harriet’s mum was diagnosed with MND in 2017, after experiencing problems with her foot. Her condition progressed over the next two years, and she eventually lost her mobility and speech. A couple of months after the diagnosis, Harriet’s aunt developed a bulbar form of the disease. The family realised straight away that there was likely to be a genetic link. They had genetic testing and it was discovered that they carried the C9orf72 gene variant. Harriet, her husband and their son moved in with her parents over her maternity leave, and she helped care for her mum. Whilst being able to support them was a privileg, there were also parts that were difficult. Harriet lost her mum and aunt within 6 weeks of each other. Other relatives have been affected by neurological disorders, which the family now consider as likely to have been caused by this gene variant. This includes Harriet’s grandmother who was diagnosed with Parkinsonism.

Harriet and her husband had recently had their first child when they found out about inherited MND in the family. Although she did not really dwell on the implications for herself, as her focus was on her mum, she decided that she needed to find out her genetic status in order to progress with her family; wanting a second child, taking the test was a no braine. Harriet went to see her mum’s neurologist, who was satisfied that she had considered the decision. Harriet had the blood test that day. She was told that the results would take 6 weeks, but waited for 3 months. Harriet’s cousin Georgia Z has since received a negative result. This came back within 6 weeks, and was given over the phone. Harriet believes the testing process should be the same for everyone, regardless of the result.

On receiving her results, Harriet was told that she carries the C9orf72 gene variant. She felt empty and disappointed, and life became difficult straightawa. She and her husband did not want their future child to go through the decisions and discussions they themselves were facing. After further research, they decided to proceed with pre-implantation genetic testing (PGT). This uses a process of IVF to ensure that only embryos that are not carrying the gene variant are implanted.

Although Harriet was optimistic, as she and her husband conceived quickly when having their first child, the IVF failed. This was devastatin, and Harriet felt at the time that she could not go through the emotional and physical toil again. Harriet has since been through a second round of IVF, which again was unsuccessful. She describes how something that was joyful and easy became clinical, painful and difficult. There was an added financial burden as having had one child, they were not eligible for this treatment on the NHS. They have since decided to try for another child without additional testing, following research into therapies targeting the C9orf72 gene variant. They are more confident than ever that there will be a cure through genetic editing therapies to prevent the gene expressing itself, especially in their children.

Although there are moments where she worries about the future, particularly when she drops something or trips over, Harriet feels at peace with her test result. She tries to maintain a healthy lifestyle, which she believes is important in staying well, and emphasises enjoying the life she has now.

Harriet has faith that treatments will be developed to slow progression in inherited forms of MND and is confident that eventually there will be a cure.

Age at interview 35

Gender Female

Making decisions over expanding their family has been difficult for Harriet and her husband, given the uncertainty of whether a future child would develop MND and the possibility of research progress.

Age at interview 35

Gender Female

Having a second child is something that Harriet and her husband feel strongly about. Knowing that she carries the C9orf72 genetic variant, they want their son to have the support of a sibling.

Age at interview 35

Gender Female

Harriet describes the physical, emotional and financial strain of going through Pre-Implantation Genetic Testing with IVF. After the first attempt failed, she wasn’t sure she could do it again, but decided to try one more round.

Age at interview 35

Gender Female

The appointment itself is fuzzy, but Harriet felt disappointed and empty. Her pre-symptomatic genetic test results “changed the future” and impacted her immediate hopes of having another child.

Age at interview 35

Gender Female

Harriet explains the reproductive options available where a gene associated with inherited MND has been identified in the family, and why she has chosen to try pre-implantation genetic testing.

Age at interview 35

Gender Female

After being told her pre-symptomatic genetic test results would take 6 weeks, Harriet put it out of her mind. She was frustrated by further delays and felt nervous and on edge.

Age at interview 35

Gender Female

Although it’s a “nasty” way to go, Harriet remembers how her mum was able to have a good life and death with MND. Most of the time she feels “if that’s my fate, that’s my fate”.

Age at interview 35

Gender Female

Harriet saw the consultant and had her bloods taken the same day for genetic testing. She felt a bit “blindsided” it was so quick, but relieved because she was sure of her decision.

Age at interview 35

Gender Female